COMMUNIQUÉS West-GlobeNewswire

-
TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic
20/02/2024 -
PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1
20/02/2024 -
Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its Lead Oncology Program
20/02/2024 -
IntelGenx Launches Preferred Share Regulation A Offering
20/02/2024 -
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
20/02/2024 -
Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial Results
20/02/2024 -
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
20/02/2024 -
Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
20/02/2024 -
Venus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
20/02/2024 -
Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action
20/02/2024 -
Theratechnologies annonce la publication d’un article dans Frontiers in Immunology qui approfondit la compréhension du mécanisme d’action moléculaire du sudocétaxel zendusortide (TH1902)
20/02/2024 -
VitalHub UK Expands Healthtech Portfolio into Middle East through a Partnership with ADHDS
20/02/2024 -
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
20/02/2024 -
RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
20/02/2024 -
Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds
20/02/2024 -
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
20/02/2024 -
Emerging Markets Report: Look Who’s Talking
20/02/2024 -
Celcuity Appoints Eldon Mayer as Chief Commercial Officer
20/02/2024 -
Kraig Biocraft Laboratories Announces New Premium Spider Silk and Pima Cotton Composite Yarn
20/02/2024
Pages